Portfolio

Company Announcements

Holding(s) in Company

Related Companies

RNS Number : 4102G
Ark Therapeutics Group PLC
03 March 2015
 



 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi



1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached: ii

Ark Therapeutics Group plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights


An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached


An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments


An event changing the breakdown of voting rights


Other (please specify):

Passive Crossing

X

3. Full name of person(s) subject to the
notification obligation: iii

Smith and Williamson Holdings Limited

4. Full name of shareholder(s)
 (if different from 3.):iv

Detailed as per Section 9   

5. Date of the transaction and date on
which the threshold is crossed or
reached: v

                                                                          27/02/2015

6. Date on which issuer notified:

                                                                            03/03/2015

7. Threshold(s) that is/are crossed or
reached: vi, vii

5%


 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type of
shares


if possible using
the ISIN CODE

Situation previous
to the triggering
transaction

Resulting situation after the triggering transaction

Number
of
Shares

Number
of
Voting
Rights

Number
of shares

Number of voting
rights

% of  voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

ORDINARY

148,121

148,121



148,121


1.06%

GB00BSZLMS59


B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial
instrument

Expiration
date xiii

Exercise/
Conversion Period xiv

Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.

% of voting
rights

N/A

N/A

N/A

N/A

N/A


C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financial
instrument

Exercise price

Expiration date xvii

Exercise/
Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 





 

 

Nominal

Delta




Total (A+B+C)

Number of voting rights

Percentage of voting rights

148,121

1.06%


 

9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable: xxi

 

 

Smith & Williamson Nominees Limited, a subsidiary of Smith & Williamson Investment Services Limited, subsidiary of Smith & Williamson Holdings Limited - 5,871 shares

 

Royal Bank of Scotland as custodian for Smith & Williamson Fund Administration Ltd., subsidiary of Smith & Williamson Investment Services Limited, a subsidiary of Smith & Williamson Holdings Limited. - 1,000,000 shares.

 

BNP Paribas as custodian for Smith & Williamson Investment Services Limited, a subsidiary of Smith & Williamson Holdings Limited - 2,250 shares.

 

BNP Paribas Securities Services as custodian for Smith & Williamson Investment Management (Ireland) Limited, a subsidiary of Smith & Williamson Holdings Limited - 140,000 shares.

 


Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will cease
to hold:

N/A

12. Date on which proxy holder will cease to hold
voting rights:

N/A



13. Additional information:



14. Contact name:


15. Contact telephone number:


 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLFMGGFZFMGKZM

Top of Page